CHR Metz

Metz, Alsace 57085

0 studies enrolling now · 1 studies all time

What they study most

Indolent Non-Hodgkin's Lymphomas

Studies at this site

• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early